Research News
Physical Activity Associated with Lower Risk of Ovarian Cancer Mortality
(April 8, 2014) A team of researchers have found that vigorous physical activity prior to ovarian cancer diagnosis was associated with a lower risk of ovarian cancer mortality. The findings were published in Gynecologic Oncology…
OCRF Research Identifies Fusion Gene Common in Ovarian Cancer
(April 7, 2014) A group of OCRF-funded researchers at Baylor College of Medicine have found a “fusion gene” that is present in 20% of high grade serous ovarian cancer patients…
Discoverer of BRCA genes said “being ignored” helped her do her research
Last week marked the 20th year anniversary of the discovery of the BRCA1 gene by Mary-Claire King, Ph.D., an American geneticist. Dr…
Updates from the 2014 Society for Gynecologic Oncology Annual Meeting
Compiled by Robin Cohen, President-Elect, Ovarian Cancer National Alliance As in years past, a wealth of clinical research into ovarian cancer was presented at the 2014 Society for Gynecologic Oncology (SGO) meeting…
2015 OCRF Requests for Proposals Now Available
(April 1, 2014) Ovarian Cancer Research Fund is now accepting Letters of Intent for its three research grant programs…
Causative mutation found for rare form of ovarian cancer affecting young women
A rare type of ovarian cancer called small cell carcinoma of the ovary, hypercalcemic type (or SCCOHT) can affect women and girls as young as 14 months old…
Vynfinit gains European approval for treatment of platinum-resistant ovarian cancer
Last week, the European Medicines Agency’s Committee for Medicinal Products for Human Use, or CHMP – the equivalent to the FDA in the United States, recommended approval for vynfinit in the treatment of some platinum resistant ovarian…
Gene Mutation Causes Rare Ovarian Cancer
(March 25, 2014) In what is being hailed as a major discovery, findings published this week indicate that researchers have discovered a gene mutation that causes Small Cell Carcinoma of the Ovary, Hypercalcemic type…
SGO Position Statement on Genetic Testing for Gynecologic Cancer
(March 20, 2014) The Society for Gynecologic Oncology has released a statement on the use of genetic testing for women with gynecologic cancer…
Avastin and Chemo for Platinum-Resistant Ovarian Cancer Increases Progression Free Survival
(March 20, 2014) A group of French researchers conducted a randomized, phase III trial (called AURELIA) combining bevacizumab (Avastin) with chemotherapy in platinum-resistant ovarian cancer…
New analysis links ovarian cancer to obesity
This week, a new analysis showed that women that are overweight or obese have a moderately higher risk of developing ovarian cancer than women at normal weight…
Weekly Carboplatin Plus Paclitaxel Improves Quality of Life
(March 14, 2014) A large European clinical trial showed that carboplatin plus paclitaxel once a week (versus every three weeks) can be an effective front-line treatment for women with advanced ovarian cancer…